NaPi2b-targeted antibody-drug conjugates and methods of use thereof
US10947317B2 · kind B2 · utility
4Cited by
13References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2017 |
| Grant date | Mar 16, 2021 |
| Priority date | — |
| Expiry date | Jul 20, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides NaPi2b-targeted antibody-drug conjugates (e.g., NaPi2b-targeted antibody-polymer-drug conjugates) that specifically bind to the extracellular region of SLC34A2, and to methods of using such conjugates in a variety of therapeutic, diagnostic, and prophylactic indications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.